• Visitors can check out the Forum FAQ by clicking this link. You have to register before you can post: click the REGISTER link above to proceed. To start viewing messages, select the forum that you want to visit from the selection below. View our Forum Privacy Policy.
  • Want to receive the latest contracting news and advice straight to your inbox? Sign up to the ContractorUK newsletter here. Every sign up will also be entered into a draw to WIN £100 Amazon vouchers!

You are not logged in or you do not have permission to access this page. This could be due to one of several reasons:

  • You are not logged in. If you are already registered, fill in the form below to log in, or follow the "Sign Up" link to register a new account.
  • You may not have sufficient privileges to access this page. Are you trying to edit someone else's post, access administrative features or some other privileged system?
  • If you are trying to post, the administrator may have disabled your account, or it may be awaiting activation.

Previously on "Britain loses medicines contracts as EU body anticipates Brexit"

Collapse

  • chopper
    replied
    Its just a jobs. Let them go, and we can boycott all EU drugs then. Life was easier before the EU, and it can be easier again when we don't have jobs to worry about. It'll be worth it.
    </gammnon>

    Leave a comment:


  • malvolio
    replied
    And all new medicines dispensed in the U.K.will need approval by MHRA, so only a minor disaster, surely?

    Leave a comment:


  • Britain loses medicines contracts as EU body anticipates Brexit

    Britain’s leading role in evaluating new medicines for sale to patients across the EU has collapsed with no more work coming from Europe because of Brexit, it has emerged.

    The decision by the European Medicines Agency to cut Britain out of its contracts seven months ahead of Brexit is a devastating blow to British pharmaceutical companies already reeling from the loss of the EMA’s HQ in London and with it 900 jobs.

    All drugs sold in Europe have to go through a lengthy EMA authorisation process before use by health services, and the Medicines & Healthcare products Regulatory Agency (MHRA) in Britain has built up a leading role in this work, with 20-30% of all assessments in the EU.

    https://www.theguardian.com/business...cipates-brexit

Working...
X